{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T08:00:43Z","timestamp":1762761643827,"version":"3.37.3"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2020,5,13]],"date-time":"2020-05-13T00:00:00Z","timestamp":1589328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,5,13]],"date-time":"2020-05-13T00:00:00Z","timestamp":1589328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["CA125456"],"award-info":[{"award-number":["CA125456"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006221","name":"Israel-USA bi-national Science Foundation","doi-asserted-by":"publisher","award":["2005331"],"award-info":[{"award-number":["2005331"]}],"id":[{"id":"10.13039\/100006221","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1007\/s00262-020-02596-7","type":"journal-article","created":{"date-parts":[[2020,5,13]],"date-time":"2020-05-13T07:04:07Z","timestamp":1589353447000},"page":"2021-2031","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Prevention of liver metastases through perioperative acute CpG-C immune stimulation"],"prefix":"10.1007","volume":"69","author":[{"given":"Liat","family":"Sorski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rivka","family":"Melamed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ben","family":"Levi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pini","family":"Matzner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hagar","family":"Lavon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ella","family":"Rosenne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lee","family":"Shaashua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Itay","family":"Ricon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elad","family":"Sandbank","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amit","family":"Benbenishty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shamgar","family":"Ben-Eliyahu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,5,13]]},"reference":[{"key":"2596_CR1","unstructured":"Ferlay J et al (2019) Global cancer observatory: cancer today. 2018 [cited 2019 2\/11\/2019]; Available from: https:\/\/gco.iarc.fr\/today"},{"issue":"7","key":"2596_CR2","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1002\/bjs.7032","volume":"97","author":"EJ Morris","year":"2010","unstructured":"Morris EJ et al (2010) Surgical management and outcomes of colorectal cancer liver metastases. Br J Surg 97(7):1110\u20131118","journal-title":"Br J Surg"},{"issue":"18","key":"2596_CR3","doi-asserted-by":"crossref","first-page":"4895","DOI":"10.1158\/1078-0432.CCR-12-1087","volume":"18","author":"E Neeman","year":"2012","unstructured":"Neeman E, Zmora O, Ben-Eliyahu S (2012) A new approach to reducing postsurgical cancer recurrence: perioperative targeting of catecholamines and prostaglandins. Clin Cancer Res 18(18):4895\u20134902","journal-title":"Clin Cancer Res"},{"issue":"4","key":"2596_CR4","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nrclinonc.2014.224","volume":"12","author":"M Horowitz","year":"2015","unstructured":"Horowitz M et al (2015) Exploiting the critical perioperative period to improve long-term cancer outcomes. Nat Rev Clin Oncol 12(4):213\u2013226","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"2596_CR5","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1097\/00000658-200007000-00009","volume":"232","author":"K Yamaguchi","year":"2000","unstructured":"Yamaguchi K et al (2000) Significant detection of circulating cancer cells in the blood by reverse transcriptase-polymerase chain reaction during colorectal cancer resection. Ann Surg 232(1):58\u201365","journal-title":"Ann Surg"},{"issue":"Suppl 1","key":"2596_CR6","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1016\/S0889-1591(02)00063-6","volume":"17","author":"S Ben-Eliyahu","year":"2003","unstructured":"Ben-Eliyahu S (2003) The promotion of tumor metastasis by surgery and stress: immunological basis and implications for psychoneuroimmunology. Brain Behav Immun 17(Suppl 1):S27\u2013S36","journal-title":"Brain Behav Immun"},{"issue":"8","key":"2596_CR7","first-page":"1996","volume":"49","author":"B Fisher","year":"1989","unstructured":"Fisher B et al (1989) Presence of a growth-stimulating factor in serum following primary tumor removal in mice. Cancer Res 49(8):1996\u20132001","journal-title":"Cancer Res"},{"issue":"16","key":"2596_CR8","doi-asserted-by":"crossref","first-page":"4651","DOI":"10.1158\/1078-0432.CCR-17-0152","volume":"23","author":"L Shaashua","year":"2017","unstructured":"Shaashua L et al (2017) Perioperative COX-2 and beta-adrenergic blockade improves metastatic biomarkers in breast cancer patients in a phase-II randomized trial. Clin Cancer Res 23(16):4651\u20134661","journal-title":"Clin Cancer Res"},{"issue":"2","key":"2596_CR9","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.bbi.2004.07.004","volume":"19","author":"R Melamed","year":"2005","unstructured":"Melamed R et al (2005) Marginating pulmonary-NK activity and resistance to experimental tumor metastasis: suppression by surgery and the prophylactic use of a beta-adrenergic antagonist and a prostaglandin synthesis inhibitor. Brain Behav Immun 19(2):114\u2013126","journal-title":"Brain Behav Immun"},{"issue":"4","key":"2596_CR10","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/BF00224305","volume":"173","author":"E Wisse","year":"1976","unstructured":"Wisse E et al (1976) The pit cell: description of a new type of cell occurring in rat liver sinusoids and peripheral blood. Cell Tissue Res 173(4):423\u2013435","journal-title":"Cell Tissue Res"},{"issue":"3","key":"2596_CR11","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/BF00212219","volume":"233","author":"K Kaneda","year":"1983","unstructured":"Kaneda K, Wake K (1983) Distribution and morphological characteristics of the pit cells in the liver of the rat. Cell Tissue Res 233(3):485\u2013505","journal-title":"Cell Tissue Res"},{"issue":"3","key":"2596_CR12","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/cmi.2013.9","volume":"10","author":"H Sun","year":"2013","unstructured":"Sun H et al (2013) NK cells in immunotolerant organs. Cell Mol Immunol 10(3):202\u2013212","journal-title":"Cell Mol Immunol"},{"issue":"8","key":"2596_CR13","doi-asserted-by":"crossref","first-page":"4943","DOI":"10.4049\/jimmunol.162.8.4943","volume":"162","author":"WE Carson","year":"1999","unstructured":"Carson WE et al (1999) A fatal cytokine-induced systemic inflammatory response reveals a critical role for NK cells. J Immunol 162(8):4943\u20134951","journal-title":"J Immunol"},{"key":"2596_CR14","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1146\/annurev.immunol.20.100301.064842","volume":"20","author":"AM Krieg","year":"2002","unstructured":"Krieg AM (2002) CpG motifs in bacterial DNA and their immune effects. Annu Rev Immunol 20:709\u2013760","journal-title":"Annu Rev Immunol"},{"issue":"4","key":"2596_CR15","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1002\/eji.200535781","volume":"36","author":"S Sivori","year":"2006","unstructured":"Sivori S et al (2006) Comparison of different CpG oligodeoxynucleotide classes for their capability to stimulate human NK cells. Eur J Immunol 36(4):961\u2013967","journal-title":"Eur J Immunol"},{"issue":"8","key":"2596_CR16","doi-asserted-by":"crossref","first-page":"3058","DOI":"10.1182\/blood-2003-08-2972","volume":"103","author":"H Poeck","year":"2004","unstructured":"Poeck H et al (2004) Plasmacytoid dendritic cells, antigen, and CpG-C license human B cells for plasma cell differentiation and immunoglobulin production in the absence of T-cell help. Blood 103(8):3058\u20133064","journal-title":"Blood"},{"issue":"22","key":"2596_CR17","doi-asserted-by":"crossref","first-page":"5134","DOI":"10.1016\/j.biomaterials.2011.03.067","volume":"32","author":"B Kwong","year":"2011","unstructured":"Kwong B, Liu H, Irvine DJ (2011) Induction of potent anti-tumor responses while eliminating systemic side effects via liposome-anchored combinatorial immunotherapy. Biomaterials 32(22):5134\u20135147","journal-title":"Biomaterials"},{"issue":"8","key":"2596_CR18","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1084\/jem.20060401","volume":"203","author":"C Guiducci","year":"2006","unstructured":"Guiducci C et al (2006) Properties regulating the nature of the plasmacytoid dendritic cell response to Toll-like receptor 9 activation. J Exp Med 203(8):1999\u20132008","journal-title":"J Exp Med"},{"issue":"3","key":"2596_CR19","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41590-018-0292-y","volume":"20","author":"M Liu","year":"2019","unstructured":"Liu M et al (2019) Metabolic rewiring of macrophages by CpG potentiates clearance of cancer cells and overcomes tumor-expressed CD47-mediated \u2018don\u2019t-eat-me\u2019 signal. Nat Immunol 20(3):265\u2013275","journal-title":"Nat Immunol"},{"issue":"9","key":"2596_CR20","first-page":"2434","volume":"35","author":"TH Corbett","year":"1975","unstructured":"Corbett TH et al (1975) Tumor induction relationships in development of transplantable cancers of the colon in mice for chemotherapy assays, with a note on carcinogen structure. Cancer Res 35(9):2434\u20132439","journal-title":"Cancer Res"},{"issue":"10","key":"2596_CR21","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1007\/s00595-013-0768-1","volume":"44","author":"L Sorski","year":"2014","unstructured":"Sorski L et al (2014) The impact of surgical extent and sex on the hepatic metastasis of colon cancer. Surg Today 44(10):1925\u20131934","journal-title":"Surg Today"},{"key":"2596_CR22","doi-asserted-by":"crossref","unstructured":"Sorski L et al. (2016) Selective harvesting of marginating-hepatic leukocytes. J Vis Exp, 113","DOI":"10.3791\/53918"},{"issue":"1","key":"2596_CR23","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/CJI.0b013e3181b0b146","volume":"33","author":"R Melamed","year":"2010","unstructured":"Melamed R et al (2010) The marginating-pulmonary immune compartment in rats: characteristics of continuous inflammation and activated NK cells. J Immunother 33(1):16\u201329","journal-title":"J Immunother"},{"issue":"4","key":"2596_CR24","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1152\/physrev.00027.2008","volume":"89","author":"B Vollmar","year":"2009","unstructured":"Vollmar B, Menger MD (2009) The hepatic microcirculation: mechanistic contributions and therapeutic targets in liver injury and repair. Physiol Rev 89(4):1269\u20131339","journal-title":"Physiol Rev"},{"issue":"4","key":"2596_CR25","first-page":"271","volume":"2","author":"J Zhang","year":"2005","unstructured":"Zhang J et al (2005) Isolation of lymphocytes and their innate immune characterizations from liver, intestine, lung and uterus. Cell Mol Immunol 2(4):271\u2013280","journal-title":"Cell Mol Immunol"},{"key":"2596_CR26","doi-asserted-by":"crossref","first-page":"716","DOI":"10.3389\/fonc.2019.00716","volume":"9","author":"DJ Agorku","year":"2019","unstructured":"Agorku DJ et al (2019) CD49b, CD87, and CD95 are markers for activated cancer-associated fibroblasts whereas CD39 marks quiescent normal fibroblasts in murine tumor models. Front Oncol 9:716","journal-title":"Front Oncol"},{"issue":"6813","key":"2596_CR27","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/35047123","volume":"408","author":"H Hemmi","year":"2000","unstructured":"Hemmi H et al (2000) A Toll-like receptor recognizes bacterial DNA. Nature 408(6813):740\u2013745","journal-title":"Nature"},{"issue":"7","key":"2596_CR28","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.4049\/jimmunol.167.7.3555","volume":"167","author":"F Takeshita","year":"2001","unstructured":"Takeshita F et al (2001) Cutting edge: role of Toll-like receptor 9 in CpG DNA-induced activation of human cells. J Immunol 167(7):3555\u20133558","journal-title":"J Immunol"},{"issue":"6","key":"2596_CR29","doi-asserted-by":"crossref","first-page":"545","DOI":"10.2174\/1566524023362159","volume":"2","author":"AA Ashkar","year":"2002","unstructured":"Ashkar AA, Rosenthal KL (2002) Toll-like receptor 9, CpG DNA and innate immunity. Curr Mol Med 2(6):545\u2013556","journal-title":"Curr Mol Med"},{"issue":"6522","key":"2596_CR30","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1038\/374546a0","volume":"374","author":"AM Krieg","year":"1995","unstructured":"Krieg AM et al (1995) CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 374(6522):546\u2013549","journal-title":"Nature"},{"issue":"7","key":"2596_CR31","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1002\/1521-4141(200107)31:7<2154::AID-IMMU2154>3.0.CO;2-U","volume":"31","author":"A Krug","year":"2001","unstructured":"Krug A et al (2001) Identification of CpG oligonucleotide sequences with high induction of IFN-alpha\/beta in plasmacytoid dendritic cells. Eur J Immunol 31(7):2154\u20132163","journal-title":"Eur J Immunol"},{"issue":"12","key":"2596_CR32","doi-asserted-by":"crossref","first-page":"3851","DOI":"10.1182\/blood-2006-02-004028","volume":"108","author":"M Della Chiesa","year":"2006","unstructured":"Della Chiesa M et al (2006) Multidirectional interactions are bridging human NK cells with plasmacytoid and monocyte-derived dendritic cells during innate immune responses. Blood 108(12):3851\u20133858","journal-title":"Blood"},{"key":"2596_CR33","doi-asserted-by":"crossref","first-page":"372","DOI":"10.3389\/fimmu.2013.00372","volume":"4","author":"TS Mathan","year":"2013","unstructured":"Mathan TS, Figdor CG, Buschow SI (2013) Human plasmacytoid dendritic cells: from molecules to intercellular communication network. Front Immunol 4:372","journal-title":"Front Immunol"},{"issue":"6","key":"2596_CR34","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1136\/gut.2007.122168","volume":"57","author":"DH Adams","year":"2008","unstructured":"Adams DH, Eksteen B, Curbishley SM (2008) Immunology of the gut and liver: a love\/hate relationship. Gut 57(6):838\u2013848","journal-title":"Gut"},{"issue":"1","key":"2596_CR35","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/nri981","volume":"3","author":"IN Crispe","year":"2003","unstructured":"Crispe IN (2003) Hepatic T cells and liver tolerance. Nat Rev Immunol 3(1):51\u201362","journal-title":"Nat Rev Immunol"},{"issue":"5","key":"2596_CR36","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.4049\/jimmunol.0901362","volume":"184","author":"MG Lassen","year":"2010","unstructured":"Lassen MG et al (2010) Intrahepatic IL-10 maintains NKG2A\u2009+\u2009Ly49- liver NK cells in a functionally hyporesponsive state. J Immunol 184(5):2693\u20132701","journal-title":"J Immunol"},{"issue":"6","key":"2596_CR37","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1002\/hep.27254","volume":"60","author":"IN Crispe","year":"2014","unstructured":"Crispe IN (2014) Immune tolerance in liver disease. Hepatology 60(6):2109\u20132117","journal-title":"Hepatology"},{"issue":"1","key":"2596_CR38","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1365-2567.2006.02479.x","volume":"120","author":"M Jinushi","year":"2007","unstructured":"Jinushi M et al (2007) Natural killer cell and hepatic cell interaction via NKG2A leads to dendritic cell-mediated induction of CD4 CD25 T cells with PD-1-dependent regulatory activities. Immunology 120(1):73\u201382","journal-title":"Immunology"},{"issue":"10","key":"2596_CR39","doi-asserted-by":"crossref","first-page":"5766","DOI":"10.4049\/jimmunol.1100370","volume":"186","author":"H Nishikado","year":"2011","unstructured":"Nishikado H et al (2011) NK cell-depleting anti-asialo GM1 antibody exhibits a lethal off-target effect on basophils in vivo. J Immunol 186(10):5766\u20135771","journal-title":"J Immunol"},{"issue":"10","key":"2596_CR40","doi-asserted-by":"crossref","first-page":"4973","DOI":"10.4049\/jimmunol.1500651","volume":"195","author":"F Victorino","year":"2015","unstructured":"Victorino F et al (2015) Tissue-resident NK cells mediate ischemic kidney injury and are not depleted by anti-asialo-GM1 antibody. J Immunol 195(10):4973\u20134985","journal-title":"J Immunol"},{"issue":"7","key":"2596_CR41","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1245\/s10434-008-9890-5","volume":"15","author":"M Benish","year":"2008","unstructured":"Benish M et al (2008) Perioperative use of beta-blockers and COX-2 inhibitors may improve immune competence and reduce the risk of tumor metastasis. Ann Surg Oncol 15(7):2042\u20132052","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"2596_CR42","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.4049\/jimmunol.0903301","volume":"184","author":"A Glasner","year":"2010","unstructured":"Glasner A et al (2010) Improving survival rates in two models of spontaneous postoperative metastasis in mice by combined administration of a beta-adrenergic antagonist and a cyclooxygenase-2 inhibitor. J Immunol 184(5):2449\u20132457","journal-title":"J Immunol"},{"issue":"2","key":"2596_CR43","doi-asserted-by":"crossref","first-page":"712","DOI":"10.4049\/jimmunol.1201837","volume":"190","author":"JF Clinthorne","year":"2013","unstructured":"Clinthorne JF et al (2013) NK cell maturation and function in C57BL\/6 mice are altered by caloric restriction. J Immunol 190(2):712\u2013722","journal-title":"J Immunol"},{"issue":"3","key":"2596_CR44","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1097\/CJI.0b013e31819a2982","volume":"32","author":"Y Goldfarb","year":"2009","unstructured":"Goldfarb Y et al (2009) CpG-C oligodeoxynucleotides limit the deleterious effects of beta-adrenoceptor stimulation on NK cytotoxicity and metastatic dissemination. J Immunother 32(3):280\u2013291","journal-title":"J Immunother"},{"issue":"1","key":"2596_CR45","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.uct.2007.11.003","volume":"3","author":"B Jahrsdorfer","year":"2008","unstructured":"Jahrsdorfer B, Weiner GJ (2008) CpG oligodeoxynucleotides as immunotherapy in cancer. Update Cancer Ther 3(1):27\u201332","journal-title":"Update Cancer Ther"}],"container-title":["Cancer Immunology, Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-020-02596-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00262-020-02596-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-020-02596-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:40:59Z","timestamp":1696120859000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00262-020-02596-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,13]]},"references-count":45,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["2596"],"URL":"https:\/\/doi.org\/10.1007\/s00262-020-02596-7","relation":{},"ISSN":["0340-7004","1432-0851"],"issn-type":[{"type":"print","value":"0340-7004"},{"type":"electronic","value":"1432-0851"}],"subject":[],"published":{"date-parts":[[2020,5,13]]},"assertion":[{"value":"24 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The Institutional Animal Care and Use Committee of Tel Aviv University approved all studies.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and ethical standards"}},{"value":"CT26 \u2013 P-13-014, MC38 \u2013 10-18-007.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Approval numbers for the experiments"}},{"value":"BALB\/c male and female mice and C57B1\/6j male and female mice were purchased from Harlan laboratories (Jerusalem, Israel) at the age of 4\u00a0weeks. Animals were housed 3\u20134 per cage at 22\u2009\u00b1\u20091\u00a0\u00b0C, on a 12:12 light\/dark cycle and were allowed ad libitum access to food and water. Animals were used at the age of 8\u201312\u00a0weeks. (Animals were age-matched between groups within each experiment.)","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Animal source"}},{"value":"<i>The CT26 tumor cell line<\/i>: CT26 tumor cells were kindly provided by Prof. Eliezer Flesher (Department of Human Microbiology, Faculty of Medicine, Tel Aviv University).","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Cell line authentication"}},{"value":"The MC38 murine colon adenocarcinoma was derived from tumor that arose in C57B1\/6 mice. Tumor cells were kindly provided by Dr. Eran Nizri (Tel Aviv Sourasky Medical center).","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"The MC38 tumor cell line"}}]}}